R. Brown

Original article Budget impact model of tobramycin inhalation solution for treatment of Pseudomonas aeruginosa in cystic fibrosis patients

P. Sacco, Jie Zhang, T. Woodward, 2010 .

Response to Campbell, Spackman, Sullivan letter to Allergy

J. Bousquet, F. Turk, R. Brown, 2008, Allergy.

Loss of Bacterial Diversity during Antibiotic Treatment of Intubated Patients Colonized with Pseudomonas aeruginosa

Eoin L. Brodie, E L Brodie, G L Andersen, 2006, Journal of Clinical Microbiology.

Pre-core mutant infections in the Canadian Inuit.

G. Minuk, R. Chaudhary, R. Brown, 2000, Journal of hepatology.

Gains on 9p are common genomic aberrations in idiopathic myelofibrosis: a comparative genomic hybridization study

J. Reilly, G. Wilson, D. Hammond, 2005, British journal of haematology.

Published Ahead of Print 4 Pseudomonas Aeruginosa with Treatment of Intubated Patients Colonized Loss of Bacterial Diversity during Antibiotic

Eoin L. Brodie, P. Hugenholtz, G. Andersen, 2022 .

Cost‐effectiveness of omalizumab in patients with severe persistent allergic asthma

J. Bousquet, F. Turk, R. Brown, 2007, Allergy.